ON THIS PAGE: You will find information about how many children learn they have this type of lymphoma each year and some general survival information. Remember, survival rates depend on several factors. To see other pages in this guide, use the colored boxes on the right side of your screen, or click “Next” at the bottom.
This year, an estimated 620 children ages 14 and younger and 420 adolescents between the ages of 15 and 19 in the United States will be diagnosed with NHL. NHL accounts for about 6% of all childhood cancers, making it the fourth most common cancer diagnosed in children. In adolescents, it accounts for 8% of all cancers and is the fifth most common diagnosed in the 15 to 19 age group. NHL occurs two to three times more often in boys than girls.
The five-year survival rate is the percentage of people who survive at least five years after the cancer is detected, excluding those who die from other diseases. The five-year survival rate for children with NHL is about 85%, but it is important to note that this depends on several factors, including the specific subtype of NHL and the stage of disease. Children with NHL who are alive and disease-free after five years are usually considered “cured” because it rare for childhood NHL to return after this much time.
Cancer survival statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of cancer, but the actual risk for a particular individual may differ. It is not possible to tell a person how long he or she will live with childhood NHL. Because the survival statistics are measured in five-year intervals, they may not represent recent advances made in the treatment or diagnosis of this cancer. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society’s publication, Cancer Facts & Figures 2014, and the ACS website.
Choose “Next” (below, right) to continue reading this guide, or use the colored boxes located on the right side of your screen to visit any section.